ピロキシカムの移行金属複合体 (Mn,Fe,Co,Ni,Zn) に関する包括的なDFT研究:計算可能な薬物設計への影響
Riaz Maira1, Muhammad Azam1, Ahmed Irfan2,3
1School of Chemistry, University of the Punjab, New Campus Lahore-54590, Punjab, Pakistan.
Journal of molecular modeling
|August 26, 2025
まとめ
この研究では,ピロキシカム金属複合体を計算的に評価し,CoとNi複合体は安定性と薬剤のような性質を高めることを明らかにしました. この発見は,より安全で効果的な薬剤設計の可能性を示唆し,薬理学的には好意的であり,有毒性は予測されません.
科学分野:
- コンピュータ化学
- 薬剤化学
- 材料科学
背景:
- 薬物-金属複合体の性質を予測することで,効果的な薬剤を設計する上で計算方法が不可欠です.
- ピロキシカムの移行金属複合体 (Mn,Fe,Co,Ni,Zn) は,薬物類似性,生物利用性,薬動性,および毒性について評価されました.
- 理論的な分析は,幾何学的な最適化と安定化効果に焦点を当てて,構造的,電子的,溶媒依存的な行動を探求した.
研究 の 目的:
- ピロキシカムの移行金属複合体の薬剤類似性,治療可能性,生物利用可能性,薬剤動力学,および毒性を計算的に評価する.
- 理論的分析を用いてこれらの複合体の構造的,電子的,溶媒依存的性質を調査する.
- 最も安定した複合体を特定し,金属イオンと溶媒の特性への影響を理解する.
主な方法:
- 密度関数理論 (DFT) は,幾何学最適化と周波数分析のためのB3LYP/6-31G (d,p) レベル.
- ADMETlab 3.0 ウェブサーバーを使用して,薬理学および毒性の予測を行う.
- マルチwf,Jmol,SHERMOで計算されたキーディスクリプター.
主要な成果:
- コバルト (Co) とニッケル (Ni) ピロキシカム複合体は,最も高い安定エネルギーを示した.
- HOMO-LUMOのエネルギーギャップと分子静電ポテンシャル (MEP) マップは,電荷の移転が強化され,反応部位が特定されました.
- ADMETの評価は,溶媒の極性および金属イオンの大きさの影響を強調して,有意な毒性のない好ましい安全性プロファイルを予測しました.
結論:
- 計算による評価は,ピロキシカム- 金属複合体の物理化学的性質と潜在的な生物利用可能性に関する貴重な洞察を提供します.
- CoとNi複合体は,薬物設計におけるさらなる調査のための有望な特性を示しています.
- この研究は,安全性と有効性を向上させる新しい金属ベースの医薬品の合理的な設計を導くために,理論的な分析の重要性を強調しています.
さらに関連する動画
関連する概念動画
02:58Crystal Field Theory - Octahedral Complexes
27.6K
Crystal Field Theory
To explain the observed behavior of transition metal complexes (such as colors), a model involving electrostatic interactions between the electrons from the ligands and the electrons in the unhybridized d orbitals of the central metal atom has been developed. This electrostatic model is crystal field theory (CFT). It helps to understand, interpret, and predict the colors, magnetic behavior, and some structures of coordination compounds of transition metals.
CFT focuses on...
To explain the observed behavior of transition metal complexes (such as colors), a model involving electrostatic interactions between the electrons from the ligands and the electrons in the unhybridized d orbitals of the central metal atom has been developed. This electrostatic model is crystal field theory (CFT). It helps to understand, interpret, and predict the colors, magnetic behavior, and some structures of coordination compounds of transition metals.
CFT focuses on...
27.6K
02:46Crystal Field Theory - Tetrahedral and Square Planar Complexes
44.4K
Tetrahedral Complexes
Crystal field theory (CFT) is applicable to molecules in geometries other than octahedral. In octahedral complexes, the lobes of the dx2−y2 and dz2 orbitals point directly at the ligands. For tetrahedral complexes, the d orbitals remain in place, but with only four ligands located between the axes. None of the orbitals points directly at the tetrahedral ligands. However, the dx2−y2 and dz2 orbitals (along the Cartesian axes) overlap with the ligands less than the dxy,...
Crystal field theory (CFT) is applicable to molecules in geometries other than octahedral. In octahedral complexes, the lobes of the dx2−y2 and dz2 orbitals point directly at the ligands. For tetrahedral complexes, the d orbitals remain in place, but with only four ligands located between the axes. None of the orbitals points directly at the tetrahedral ligands. However, the dx2−y2 and dz2 orbitals (along the Cartesian axes) overlap with the ligands less than the dxy,...
44.4K
03:02Colors and Magnetism
12.3K
Color in Coordination Complexes
When atoms or molecules absorb light at the proper frequency, their electrons are excited to higher-energy orbitals. For many main group atoms and molecules, the absorbed photons are in the ultraviolet range of the electromagnetic spectrum, which cannot be detected by the human eye. For coordination compounds, the energy difference between the d orbitals often allows photons in the visible range to be absorbed and emitted, which is seen as colors by the human...
When atoms or molecules absorb light at the proper frequency, their electrons are excited to higher-energy orbitals. For many main group atoms and molecules, the absorbed photons are in the ultraviolet range of the electromagnetic spectrum, which cannot be detected by the human eye. For coordination compounds, the energy difference between the d orbitals often allows photons in the visible range to be absorbed and emitted, which is seen as colors by the human...
12.3K
02:42Valence Bond Theory
9.4K
Coordination compounds and complexes exhibit different colors, geometries, and magnetic behavior, depending on the metal atom/ion and ligands from which they are composed. In an attempt to explain the bonding and structure of coordination complexes, Linus Pauling proposed the valence bond theory, or VBT, using the concepts of hybridization and the overlapping of the atomic orbitals. According to VBT, the central metal atom or ion (Lewis acid) hybridizes to provide empty orbitals of suitable...
9.4K
01:09Complexation Equilibria: Factors Influencing Stability of Complexes
471
In complexation reactions, metal cations are the electron pair acceptors, and the ligands are the electron pair donors. The stability of the metal complexes depends primarily on the complexing ability of the central metal ion and the nature of the ligands. Generally, the complexing ability of the metal ion depends on the size and charge of the ion. As the metal ion size increases, the stability of the metal complexes decreases, provided that the valency of the metal ion and the ligands remain...
471
01:28Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K